Global Analysis of the Glycoproteome in Saccharomyces Cerevisiae Reveals New Roles for Protein Glycosylation in Eukaryotes
Overview
Affiliations
To further understand the roles of protein glycosylation in eukaryotes, we globally identified glycan-containing proteins in yeast. A fluorescent lectin binding assay was developed and used to screen protein microarrays containing over 5000 proteins purified from yeast. A total of 534 yeast proteins were identified that bound either Concanavalin A (ConA) or Wheat-Germ Agglutinin (WGA); 406 of them were novel. Among the novel glycoproteins, 45 were validated by mobility shift upon treatment with EndoH and PNGase F, thereby extending the number of validated yeast glycoproteins to 350. In addition to many components of the secretory pathway, we identified other types of proteins, such as transcription factors and mitochondrial proteins. To further explore the role of glycosylation in mitochondrial function, the localization of four mitochondrial proteins was examined in the presence and absence of tunicamycin, an inhibitor of N-linked protein glycosylation. For two proteins, localization to the mitochondria is diminished upon tunicamycin treatment, indicating that protein glycosylation is important for protein function. Overall, our studies greatly extend our understanding of protein glycosylation in eukaryotes through the cataloguing of glycoproteins, and describe a novel role for protein glycosylation in mitochondrial protein function and localization.
An autoantibody profile identified by human genome-wide protein arrays in rheumatoid arthritis.
Liu X, Zhang X, Kang Y, Huang F, Liu S, Guo Y MedComm (2020). 2024; 5(8):e679.
PMID: 39132510 PMC: 11317183. DOI: 10.1002/mco2.679.
Peng M, Mathew N, Anderson V, Falk M, Nakamaru-Ogiso E bioRxiv. 2024; .
PMID: 39026824 PMC: 11257584. DOI: 10.1101/2024.07.09.602756.
Characterization of Mannoprotein Structural Diversity in Wine Yeast Species.
Snyman C, Mekoue Nguela J, Sieczkowski N, Divol B, Marangon M J Agric Food Chem. 2023; 71(49):19727-19738.
PMID: 38049383 PMC: 10722544. DOI: 10.1021/acs.jafc.3c05742.
EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma.
Martija A, Krauss A, Bachle N, Doth L, Christians A, Krunic D Acta Neuropathol Commun. 2023; 11(1):177.
PMID: 37936247 PMC: 10629159. DOI: 10.1186/s40478-023-01673-z.
Bandini G, Damerow S, Sempaio Guther M, Guo H, Mehlert A, Paredes Franco J Elife. 2021; 10.
PMID: 34410224 PMC: 8439653. DOI: 10.7554/eLife.70272.